Search Results 91-100 of 16075 for pharmacogenetics
Alzheimer's disease (AD) is likely influenced by the interaction of many genetic and environmental factors, some of which may act by influencing brain gene ...
The center has established service lines in cancer, rare and undiagnosed diseases, pharmacogenomics, and predictive genomics and is integrating these services ...
Corifact™ or Tretten® is a man-made protein produced to replicate the naturally occurring factor XIII in the body. It is used to stop bleeding by helping the ...
For the first time, a team of scientists led by the National Institutes of Health has finished sequencing an entire human genome — all of the roughly 3 billion ...
... pharmacogenetic studies in clinical protocols to include development and validation of assays for genetic variants of proteins associated with drug response.
The role of pharmacogenetics in personalizing the antidepressant and anxiolytic therapy. Genes. 2023; doi:10.3390/genes14051095. Henssler J, et al ...
From Alzheimer's disease and asthma to diabetes and a chemotherapy drug, researchers at Mayo Clinic are tapping the Sangre Por Salud (Spanish for "Blood for ...
The Center for Individualized Medicine aligns its programs across four pillars: Functional Omics, Digital Omics, Population Omics and Rare Disease Omics.
In one study, she investigates a series of biomarkers related to the initial treatment for patients with estrogen receptor-positive, or ER+, breast cancer with ...
About this study. Tapestry is a Mayo Clinic research study, which includes receiving genetic sequencing data from Helix, up to the full whole exome dataset.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.